
Madrigal Pharma
web2Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therap...
Symbol · 1MDGL
Company profile
About
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Explore by sector
Explore this sector
Market identity
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
ExchangeNasdaqPrimary symbol: 1MDGL
ExchangeMilanPrimary symbol: 1MDGL
Expert coverage
1 expert evaluated Madrigal Pharma.
Orbitrum research
Experts evaluating Madrigal Pharma
Explore the public profiles of experts who have evaluated this project.
Orbitrum Academy